The proteomic model significantly improved kidney cancer risk prediction compared to the clinical model (concordance index [C-index]: 0.811 vs. 0.713, P = 0.029), with HAVCR1 alone demonstrating comparable discriminative ability (C-index: 0.754). Here, HAVCR1 is linked to kidney cancer.